Works matching AU Piccart, Martine

Results: 174
    1

    Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.

    Published in:
    2019
    By:
    • Lambertini, Matteo;
    • Martel, Samuel;
    • Campbell, Christine;
    • Guillaume, Sébastien;
    • Hilbers, Florentine S.;
    • Schuehly, Uwe;
    • Korde, Larissa;
    • Azim, Hatem A.;
    • Di Cosimo, Serena;
    • Tenglin, Richard C.;
    • Huober, Jens;
    • Baselga, José;
    • Moreno‐Aspitia, Alvaro;
    • Piccart‐Gebhart, Martine;
    • Gelber, Richard D.;
    • de Azambuja, Evandro;
    • Ignatiadis, Michail;
    • Azim, Hatem A , Jr;
    • Moreno-Aspitia, Alvaro;
    • Piccart-Gebhart, Martine
    Publication type:
    journal article
    2

    Survival Impact and Cost‐Effectiveness of a Multidisciplinary Tumor Board for Breast Cancer in Mozambique, Sub‐Saharan Africa.

    Published in:
    Oncologist, 2021, v. 26, n. 6, p. e996, doi. 10.1002/onco.13643
    By:
    • Brandão, Mariana;
    • Guisseve, Assucena;
    • Bata, Genoveva;
    • Firmino‐Machado, João;
    • Alberto, Matos;
    • Ferro, Josefo;
    • Garcia, Carlos;
    • Zaqueu, Clésio;
    • Jamisse, Astrilde;
    • Lorenzoni, Cesaltina;
    • Piccart‐Gebhart, Martine;
    • Leitão, Dina;
    • Come, Jotamo;
    • Soares, Otília;
    • Gudo‐Morais, Alberto;
    • Schmitt, Fernando;
    • Tulsidás, Satish;
    • Carrilho, Carla;
    • Lunet, Nuno
    Publication type:
    Article
    3

    Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-54621-3
    By:
    • Rediti, Mattia;
    • Venet, David;
    • Joaquin Garcia, Andrea;
    • Maetens, Marion;
    • Vincent, Delphine;
    • Majjaj, Samira;
    • El-Abed, Sarra;
    • Di Cosimo, Serena;
    • Ueno, Takayuki;
    • Izquierdo, Miguel;
    • Piccart, Martine;
    • Pusztai, Lajos;
    • Loi, Sherene;
    • Salgado, Roberto;
    • Viale, Giuseppe;
    • Rothé, Françoise;
    • Sotiriou, Christos
    Publication type:
    Article
    4
    5

    Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.

    Published in:
    2021
    By:
    • Bines, José;
    • Clark, Emma;
    • Barton, Claire;
    • Restuccia, Eleonora;
    • Procter, Marion;
    • Sonnenblick, Amir;
    • Fumagalli, Debora;
    • Parlier, Damien;
    • Arahmani, Amal;
    • Baselga, José;
    • Viale, Giuseppe;
    • Reaby, Linda L.;
    • Frank, Elizabeth;
    • Gelber, Richard D.;
    • Piccart, Martine;
    • Jackisch, Christian;
    • Petersen, Jennifer A.
    Publication type:
    journal article
    6
    7
    8

    Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis.

    Published in:
    2014
    By:
    • Yardley, Denise;
    • Noguchi, Shinzaburo;
    • Pritchard, Kathleen;
    • Burris, Howard;
    • Baselga, José;
    • Gnant, Michael;
    • Hortobagyi, Gabriel;
    • Campone, Mario;
    • Pistilli, Barbara;
    • Piccart, Martine;
    • Melichar, Bohuslav;
    • Petrakova, Katarina;
    • Arena, Francis;
    • Erdkamp, Frans;
    • Harb, Wael;
    • Feng, Wentao;
    • Cahana, Ayelet;
    • Taran, Tetiana;
    • Lebwohl, David;
    • Rugo, Hope
    Publication type:
    Erratum
    9

    Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis.

    Published in:
    2013
    By:
    • Yardley, Denise A;
    • Noguchi, Shinzaburo;
    • Pritchard, Kathleen I;
    • Burris 3rd, Howard A;
    • Baselga, José;
    • Gnant, Michael;
    • Hortobagyi, Gabriel N;
    • Campone, Mario;
    • Pistilli, Barbara;
    • Piccart, Martine;
    • Melichar, Bohuslav;
    • Petrakova, Katarina;
    • Arena, Francis P;
    • Erdkamp, Frans;
    • Harb, Wael A;
    • Feng, Wentao;
    • Cahana, Ayelet;
    • Taran, Tetiana;
    • Lebwohl, David;
    • Rugo, Hope S
    Publication type:
    journal article
    10

    Everolimus Plus Exemestane in Postmenopausal Patients with HR<sup>+</sup> Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis.

    Published in:
    Advances in Therapy, 2013, v. 30, n. 10, p. 870, doi. 10.1007/s12325-013-0060-1
    By:
    • Yardley, Denise A.;
    • Noguchi, Shinzaburo;
    • Pritchard, Kathleen I.;
    • Burris III, Howard A.;
    • Baselga, José;
    • Gnant, Michael;
    • Hortobagyi, Gabriel N.;
    • Campone, Mario;
    • Pistilli, Barbara;
    • Piccart, Martine;
    • Melichar, Bohuslav;
    • Petrakova, Katarina;
    • Arena, Francis P.;
    • Erdkamp, Frans;
    • Harb, Wael A.;
    • Feng, Wentao;
    • Cahana, Ayelet;
    • Taran, Tetiana;
    • Lebwohl, David;
    • Rugo, Hope S.
    Publication type:
    Article
    11

    <sup>18</sup>F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.

    Published in:
    Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1862, doi. 10.2967/jnumed.112.119271
    By:
    • Gebhart, Geraldine;
    • Gámez, Cristina;
    • Holmes, Eileen;
    • Robles, Javier;
    • Garcia, Camilo;
    • Cortés, Montserrat;
    • de Azambuja, Evandro;
    • Fauria, Karine;
    • Van Dooren, Veerle;
    • Aktan, Gursel;
    • Coccia-Portugal, Maria Antonia;
    • Sung-Bae Kim;
    • Vuylsteke, Peter;
    • Cure, Hervé;
    • Eidtmann, Holger;
    • Baselga, José;
    • Piccart, Martine;
    • Flamen, Patrick;
    • Di Cosimo, Serena
    Publication type:
    Article
    12
    13

    Keeping faith with trial volunteers.

    Published in:
    Nature, 2007, v. 446, n. 7132, p. 137, doi. 10.1038/446137a
    By:
    • Piccart, Martine;
    • Goldhirsch, Aron;
    • Wood, William;
    • Pritchard, Kathleen;
    • Baselga, José;
    • Reaby, Linda;
    • Kössler, Ingrid;
    • Kyriakides, Stella;
    • Norton, Larry;
    • Coates, Alan
    Publication type:
    Article
    14

    Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial.

    Published in:
    Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-1111-1
    By:
    • Jacob, Laurent;
    • Witteveen, Anke;
    • Beumer, Inès;
    • Delahaye, Leonie;
    • Wehkamp, Diederik;
    • van den Akker, Jeroen;
    • Snel, Mireille;
    • Chan, Bob;
    • Floore, Arno;
    • Bakx, Niels;
    • Brink, Guido;
    • Poncet, Coralie;
    • Bogaerts, Jan;
    • Delorenzi, Mauro;
    • Piccart, Martine;
    • Rutgers, Emiel;
    • Cardoso, Fatima;
    • Speed, Terence;
    • van 't Veer, Laura;
    • Glas, Annuska
    Publication type:
    Article
    15

    Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience.

    Published in:
    Oncologist, 2013, v. 18, n. 2, p. 134, doi. 10.1634/theoncologist.2012-0342
    By:
    • Metzger‐Filho, Otto;
    • Azambuja, Evandro;
    • Bradbury, Ian;
    • Saini, Kamal S.;
    • Bines, José;
    • Simon, Sergio D.;
    • Van Dooren, Veerle;
    • Aktan, Gursel;
    • Pritchard, Kathleen I.;
    • Wolff, Antonio C.;
    • Smith, Ian;
    • Jackisch, Christian;
    • Lang, Istvan;
    • Untch, Michael;
    • Boyle, Frances;
    • Xu, Binghe;
    • Baselga, Jose;
    • Perez, Edith A.;
    • Piccart‐Gebhart, Martine
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    PB2707: ESMO‐MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO‐MCBS:H) VERSION 1.0.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000977500.02308.e3
    By:
    • Kiesewetter, Barbara;
    • Dafni, Urania;
    • de Vries, Elisabeth G E;
    • Barriuso, Jorge;
    • Curigliano, Giuseppe;
    • González‐Calle, Veronica;
    • Galotti, Martina;
    • Gyawali, Bishal;
    • Huntly, Brian;
    • Jaeger, Ulrich;
    • Latino, Nicola Jane;
    • Malcovati, Luca;
    • Oosting, Sjoukje;
    • Ossenkoppele, Gert;
    • Piccart, Martine;
    • Raderer, Markus;
    • Scarfò, Lydia;
    • Trapani, Dario;
    • Zielinski, Christoph C;
    • Wester, Ruth
    Publication type:
    Article
    29

    p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.

    Published in:
    International Journal of Oncology, 2018, v. 52, n. 2, p. 424, doi. 10.3892/ijo.2017.4212
    By:
    • Sonnenblick, Amir;
    • Salgado, Roberto;
    • Brohée, Sylvain;
    • Zahavi, Tamar;
    • Peretz, Tamar;
    • Van Den Eynden, Gert;
    • Rouas, Ghizlane;
    • Salmon, Asher;
    • Francis, Prudence A.;
    • Di Leo, Angelo;
    • Crown, John P.A.;
    • Viale, Giuseppe;
    • Daly, Laura;
    • Javdan, Bahar;
    • Fujisawa, Sho;
    • De Azambuja, Evandro;
    • Lieveke, Ameye;
    • Piccart, Martine J.;
    • Bromberg, Jacqueline F.;
    • Sotiriou, Christos
    Publication type:
    Article
    30

    Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid structures in Human Breast cancer.

    Published in:
    Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01412
    By:
    • Solinas, Cinzia;
    • Garaud, Soizic;
    • De Silva, Pushpamali;
    • Boisson, Anaïs;
    • Van den Eynden, Gert;
    • de Wind, Alexandre;
    • Risso, Paolo;
    • Vitória, Joel Rodrigues;
    • Richard, François;
    • Migliori, Edoardo;
    • Noël, Grégory;
    • Duvillier, Hugues;
    • Craciun, Ligia;
    • Veys, Isabelle;
    • Awada, Ahmad;
    • Detours, Vincent;
    • Larsimont, Denis;
    • Piccart-Gebhart, Martine;
    • Willard-Gallo, Karen
    Publication type:
    Article
    31
    32

    Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

    Published in:
    PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0154009
    By:
    • Ignatiadis, Michail;
    • Zardavas, Dimitrios;
    • Lemort, Marc;
    • Wilke, Celine;
    • Vanderbeeken, Marie-Catherine;
    • D’Hondt, Veronique;
    • De Azambuja, Evandro;
    • Gombos, Andrea;
    • Lebrun, Fabienne;
    • Dal Lago, Lissandra;
    • Bustin, Fanny;
    • Maetens, Marion;
    • Ameye, Lieveke;
    • Veys, Isabelle;
    • Michiels, Stefan;
    • Paesmans, Marianne;
    • Larsimont, Denis;
    • Sotiriou, Christos;
    • Nogaret, Jean-Marie;
    • Piccart, Martine
    Publication type:
    Article
    33
    34
    35

    Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGICC) consensus and recommendations.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 19, p. 3251, doi. 10.1002/cncr.35389
    By:
    • Elghazaly, Hesham;
    • Azim, Hamdy A.;
    • Rugo, Hope S.;
    • Cameron, David;
    • Swain, Sandra M.;
    • Curigliano, Giuseppe;
    • Harbeck, Nadia;
    • Tripathy, Debu;
    • Arun, Banu;
    • Aapro, Matti;
    • Piccart, Martine;
    • Cardoso, Fatima;
    • Gligorov, Joseph;
    • Elghazawy, Hagar;
    • El Saghir, Nagi S.;
    • Penault‐Llorca, Frederique;
    • Perez, Edith A.;
    • Poortmans, Philip;
    • Abdelaziz, Hany;
    • El‐Zawahry, Heba M.
    Publication type:
    Article
    36

    Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.

    Published in:
    International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1386, doi. 10.3390/ijms21041386
    By:
    • Di Cosimo, Serena;
    • Appierto, Valentina;
    • Pizzamiglio, Sara;
    • Silvestri, Marco;
    • Baselga, José;
    • Piccart, Martine;
    • Huober, Jens;
    • Izquierdo, Miguel;
    • de la Pena, Lorena;
    • Hilbers, Florentine S.;
    • de Azambuja, Evandro;
    • Untch, Michael;
    • Pusztai, Lajos;
    • Pritchard, Kathleen;
    • Nuciforo, Paolo;
    • Vincent-Salomon, Anne;
    • Symmans, Fraser;
    • Apolone, Giovanni;
    • de Braud, Filippo G.;
    • Iorio, Marilena V.
    Publication type:
    Article
    37
    38
    39
    40
    41

    Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-023-00610-6
    By:
    • Mileva, Magdalena;
    • de Vries, Elisabeth G. E.;
    • Guiot, Thomas;
    • Wimana, Zéna;
    • Deleu, Anne-Leen;
    • Schröder, Carolien P.;
    • Lefebvre, Yolene;
    • Paesmans, Marianne;
    • Stroobants, Sigrid;
    • Huizing, Manon;
    • Aftimos, Philippe;
    • Tol, Jolien;
    • Van der Graaf, Winette T. A.;
    • Oyen, Wim J. G.;
    • Vugts, Danielle J.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Brouwers, Adrienne H.;
    • Piccart-Gebhart, Martine;
    • Flamen, Patrick;
    • Gebhart, Géraldine
    Publication type:
    Article
    42
    43
    44

    Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00467-1
    By:
    • Rugo, Hope S.;
    • Tolaney, Sara M.;
    • Loirat, Delphine;
    • Punie, Kevin;
    • Bardia, Aditya;
    • Hurvitz, Sara A.;
    • O'Shaughnessy, Joyce;
    • Cortés, Javier;
    • Diéras, Véronique;
    • Carey, Lisa A.;
    • Gianni, Luca;
    • Piccart, Martine J.;
    • Loibl, Sibylle;
    • Goldenberg, David M.;
    • Hong, Quan;
    • Olivo, Martin;
    • Itri, Loretta M.;
    • Kalinsky, Kevin
    Publication type:
    Article
    45

    PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00452-8
    By:
    • Agostinetto, Elisa;
    • Ameye, Lieveke;
    • Martel, Samuel;
    • Aftimos, Philippe;
    • Pondé, Noam;
    • Maurer, Christian;
    • El-Abed, Sarra;
    • Wang, Yingbo;
    • Vicente, Malou;
    • Chumsri, Saranya;
    • Bliss, Judith;
    • Kroep, Judith;
    • Colleoni, Marco;
    • Petrelli, Fausto;
    • Del Mastro, Lucia;
    • Moreno-Aspitia, Alvaro;
    • Piccart, Martine;
    • Paesmans, Marianne;
    • de Azambuja, Evandro;
    • Lambertini, Matteo
    Publication type:
    Article
    46

    Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00439-5
    By:
    • Carey, Lisa A.;
    • Loirat, Delphine;
    • Punie, Kevin;
    • Bardia, Aditya;
    • Diéras, Véronique;
    • Dalenc, Florence;
    • Diamond, Jennifer R.;
    • Fontaine, Christel;
    • Wang, Grace;
    • Rugo, Hope S.;
    • Hurvitz, Sara A.;
    • Kalinsky, Kevin;
    • O'Shaughnessy, Joyce;
    • Loibl, Sibylle;
    • Gianni, Luca;
    • Piccart, Martine;
    • Zhu, Yanni;
    • Delaney, Rosemary;
    • Phan, See;
    • Cortés, Javier
    Publication type:
    Article
    47

    Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

    Published in:
    2022
    By:
    • Gombos, Andrea;
    • Venet, David;
    • Ameye, Lieveke;
    • Vuylsteke, Peter;
    • Neven, Patrick;
    • Richard, Vincent;
    • Duhoux, Francois P.;
    • Laes, Jean-Francois;
    • Rothe, Françoise;
    • Sotiriou, Christos;
    • Paesmans, Marianne;
    • Awada, Ahmad;
    • Guiot, Thomas;
    • Flamen, Patrick;
    • Piccart-Gebhart, Martine;
    • Ignatiadis, Michail;
    • Gebhart, Géraldine
    Publication type:
    Correction Notice
    48

    FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

    Published in:
    NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00331-8
    By:
    • Gombos, Andrea;
    • Venet, David;
    • Ameye, Lieveke;
    • Vuylsteke, Peter;
    • Neven, Patrick;
    • Richard, Vincent;
    • Duhoux, Francois P.;
    • Laes, Jean-Francois;
    • Rothe, Françoise;
    • Sotiriou, Christos;
    • Paesmans, Marianne;
    • Awada, Ahmad;
    • Guiot, Thomas;
    • Flamen, Patrick;
    • Piccart-Gebhart, Martine;
    • Ignatiadis, Michail;
    • Gebhart, Géraldine
    Publication type:
    Article
    49

    Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy.

    Published in:
    2022
    By:
    • Lambertini, Matteo;
    • Fielding, Shona;
    • Loibl, Sibylle;
    • Janni, Wolfgang;
    • Clark, Emma;
    • Franzoi, Maria Alice;
    • Fumagalli, Debora;
    • Caballero, Carmela;
    • Arecco, Luca;
    • Salomoni, Sharon;
    • Ponde, Noam F;
    • Poggio, Francesca;
    • Kim, Hee Jeong;
    • Villarreal-Garza, Cynthia;
    • Pagani, Olivia;
    • Paluch-Shimon, Shani;
    • Ballestrero, Alberto;
    • Mastro, Lucia Del;
    • Piccart, Martine;
    • Bines, Jose
    Publication type:
    journal article
    50